These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20666266)

  • 1. Mid-term outcome of patients with Kawasaki disease, single-centre experience.
    Gillebert C; Vandeyk K; Troost E; Gewillig M; Budts W
    Acta Cardiol; 2010 Jun; 65(3):291-5. PubMed ID: 20666266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].
    Liu F; Zhao L; Wu L; Liang X; Chu C; He L; Huang G
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):690-5. PubMed ID: 26757970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan.
    Tsuda E; Kitamura S;
    Circulation; 2004 Sep; 110(11 Suppl 1):II61-6. PubMed ID: 15364840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac involvement in Kawasaki disease. Our experience].
    Sciacca P; Falsaperla R; Barone P; Tornambene G; Mattia C; Marletta M; Betta P; Distefano G
    Minerva Pediatr; 2001 Apr; 53(2):87-93. PubMed ID: 11404729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki disease.
    Scuccimarri R
    Pediatr Clin North Am; 2012 Apr; 59(2):425-45. PubMed ID: 22560578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease in a paediatric hospital in Riyadh.
    Ghazal SS; Alhowasi M; el Samady MM
    Ann Trop Paediatr; 1998 Dec; 18(4):295-9. PubMed ID: 9924585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.
    Dhanrajani A; Yeung RSM
    Curr Opin Rheumatol; 2017 Sep; 29(5):547-552. PubMed ID: 28661936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki Disease - A Review of Treatment and Outcomes in an Irish Paediatric Cohort 2010-14.
    Flinn AM; Gavin PJ; McMahon CJ; Oslizok P; Butler KM
    Ir Med J; 2018 Feb; 111(2):691. PubMed ID: 29952440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kawasaki disease in older children and young adults: 10 years of experience in Marseille, France].
    Bresson V; Bonello B; Rousset-Rouvière C; Serratrice J; Chabrol B; Dubus JC; Bosdure E
    Arch Pediatr; 2011 Jul; 18(7):731-6. PubMed ID: 21600744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of atypical Kawasaki disease.
    Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Kawasaki disease in infants younger than six months of age.
    Chang FY; Hwang B; Chen SJ; Lee PC; Meng CC; Lu JH
    Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
    Calabri GB; Falcini F; Favilli S; Pollini I; Capuzzo L; Simonini G; De Simone L
    Pediatr Med Chir; 2002; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and course of Kawasaki disease in central Tunisia: a study about 14 cases collected over a period of three years (2000-2002)].
    Chemli J; Kchaou H; Amri F; Belkadhi A; Essoussi AS; Gueddiche N; Harbi A
    Tunis Med; 2005 Aug; 83(8):477-83. PubMed ID: 16238276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K
    J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease.
    Newburger JW; Fulton DR
    Curr Opin Pediatr; 2004 Oct; 16(5):508-14. PubMed ID: 15367843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in Kawasaki syndrome.
    Rowley AH
    Adv Pediatr Infect Dis; 1997; 13():127-41. PubMed ID: 9544310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.